IMMUNO-COV™ is a high throughput assay that measures the quantity of neutralizing antibodies, which block infection, in a sample of plasma or serum.

Assay features:

• Surrogate virus encodes SARS-CoV-2 spike protein (used to infect cells): surrogate virus neutralization mimics that of SARS-CoV-2
• Surrogate virus encodes luciferase: facilitates high-throughput detection of virus infection and neutralization
• Assay cells overexpressing ACE-2: improves assay sensitivity/accuracy
• Compatible sample types: plasma and serum